175 results on '"Kristensen, Søren L."'
Search Results
2. Association of multiple sclerosis with incident diabetes: A nationwide cohort study
3. Long-Term Medical Treatment and Adherence in Patients With Left Ventricular Assist Devices: A Danish Nationwide Cohort Study
4. Hemodialysis and its impact on patient characteristics, microbiology, cardiac surgery, and mortality in infective endocarditis
5. Patient characteristics and long-term outcomes in patients undergoing transcatheter aortic valve implantation in a failed surgical prosthesis vs in a native valve: A Danish nationwide study
6. Cardiovascular and mortality outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A meta-analysis with the FREEDOM cardiovascular outcomes trial
7. Socio‐economic position, multimorbidity, and health care utilization among Danish left ventricular assist device patients.
8. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
9. Long-Term Cardiovascular Outcomes in Systemic Lupus Erythematosus
10. Risk Factors for Morbidity and Mortality Following Hospitalization for Pericarditis
11. Association of carpal tunnel syndrome with incident diabetes.
12. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
13. Burden and Causes of Hospital Admissions in Heart Failure During the Last Year of Life
14. Socioeconomic Disparities in Referral for Invasive Hemodynamic Evaluation for Advanced Heart Failure: A Nationwide Cohort Study
15. Low-Dose Aspirin in Heart Failure Not Complicated by Atrial Fibrillation: A Nationwide Propensity-Matched Study
16. Return to the workforce following coronary artery bypass grafting: A Danish nationwide cohort study
17. Evidence-Based Therapy and Its Association With Workforce Detachment After First Hospitalization for Heart Failure
18. Heart Failure in Young Adults Is Associated With High Mortality: A Contemporary Population-Level Analysis
19. Mortality in heart failure with and without autoimmune disease.
20. Trends in Medical and Device Therapies Following Incident Heart Failure in Denmark during 1996–2019: A Nationwide Register-Based Follow-Up Study.
21. Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes
22. N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status
23. Relative Importance of History of Heart Failure Hospitalization and N-Terminal Pro–B-Type Natriuretic Peptide Level as Predictors of Outcomes in Patients With Heart Failure and Preserved Ejection Fraction
24. The New Pooled Cohort Equations Risk Calculator
25. Employment status at time of first hospitalization for heart failure is associated with a higher risk of death and rehospitalization for heart failure
26. Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial
27. Ventricular rate in atrial fibrillation and the risk of heart failure and death.
28. Ongoing treatment with non-steroidal anti-inflammatory drugs at time of admission is associated with poorer prognosis in patients with first-time acute myocardial infarction
29. SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
30. Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction)
31. Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction
32. SGLT2 Inhibitors in Patients With Heart Failure and Chronic Kidney Disease: Jigsaw Falling Into Place.
33. Return to work after acute myocardial infarction with cardiogenic shock: a Danish nationwide cohort study.
34. Erratum to: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
35. Ischemic Stroke Severity and Mortality in Patients With and Without Atrial Fibrillation.
36. Long-term prognosis following hospitalization for acute myocarditis – a matched nationwide cohort study.
37. The effect of sodium‐glucose transport protein 2 inhibitors on mortality and heart failure in randomized trials versus observational studies.
38. Initiation of domiciliary care and nursing home admission following first hospitalization for heart failure, stroke, chronic obstructive pulmonary disease or cancer.
39. Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM-HF
40. Low-Dose Aspirin in Heart Failure Not Complicated by Atrial Fibrillation:A Nationwide Propensity-Matched Study
41. Employment status at time of first hospitalization for heart failure is associated with death and rehospitalization for heart failure
42. Initiation of domiciliary care and nursing home admission following first hospitalization for heart failure: a nationwide cohort study
43. Evidence based therapy and its association with workforce detachment following first hospitalization for heart failure
44. Clinical and echocardiographic characteristics and cardiovascular outcomes according to diabetes status in patients with heart failure and preserved ejection fraction. A report from the Irbesartan in Heart Failure with Preserved Ejection Fraction Trial (I-Preserve)
45. Return to the workforce following first hospitalization for heart failure: a Danish nationwide cohort study
46. Risk of heart failure in type 2 diabetes complicated by incident ischaemic heart disease and end-stage renal disease.
47. Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction
48. The effect of implantable cardioverter-defibrillator in patients with diabetes and non-ischaemic systolic heart failure.
49. The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes.
50. Microvascular complications in diabetes patients with heart failure and reduced ejection fraction-insights from the Beta-blocker Evaluation of Survival Trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.